1. Home
  2. NTST vs NUVB Comparison

NTST vs NUVB Comparison

Compare NTST & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

N/A

Current Price

$17.88

Market Cap

2.0B

Sector

Real Estate

ML Signal

N/A

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

N/A

Current Price

$4.64

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTST
NUVB
Founded
2019
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
NTST
NUVB
Price
$17.88
$4.64
Analyst Decision
Buy
Strong Buy
Analyst Count
20
13
Target Price
★ $21.20
$13.00
AVG Volume (30 Days)
1.7M
★ 5.2M
Earning Date
10-21-2026
11-04-2026
Dividend Yield
★ 5.14%
N/A
EPS Growth
★ 150.00
71.56
EPS
★ 0.20
N/A
Revenue
★ $195,006,000.00
$62,902,000.00
Revenue This Year
$30.05
$209.36
Revenue Next Year
$21.08
$41.60
P/E Ratio
$87.28
★ N/A
Revenue Growth
19.79
★ 698.96
52 Week Low
$16.18
$3.92
52 Week High
$22.47
$9.75

Technical Indicators

Market Signals
Indicator
NTST
NUVB
Relative Strength Index (RSI) 54.09 40.19
Support Level $17.89 $4.10
Resistance Level $20.99 $5.11
Average True Range (ATR) 0.46 0.23
MACD 0.16 0.06
Stochastic Oscillator 96.41 52.03

Price Performance

Historical Comparison
NTST
NUVB

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: